{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:26:26Z","timestamp":1791206786818,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,10,25]],"date-time":"2009-10-25T00:00:00Z","timestamp":1256428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/ng.470","type":"journal-article","created":{"date-parts":[[2009,10,25]],"date-time":"2009-10-25T15:34:23Z","timestamp":1256484863000},"page":"1247-1252","source":"Crossref","is-referenced-by-count":185,"title":["Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors"],"prefix":"10.1038","volume":"41","author":[{"given":"Anne","family":"Goriely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M S","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira B","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge A","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grete Krag","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne P","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilean A T","family":"McVean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa Rajpert-De","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew O M","family":"Wilkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,25]]},"reference":[{"key":"BFng470_CR1","first-page":"469","volume":"60","author":"JM Friedman","year":"1997","unstructured":"Friedman, J.M. Genetics and epidemiology, congenital anomalies and cancer. Am. J. Hum. Genet. 60, 469\u2013473 (1997).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng470_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrc2109","volume":"7","author":"S Schubbert","year":"2007","unstructured":"Schubbert, S., Shannon, K. & Bollag, G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 7, 295\u2013308 (2007).","journal-title":"Nat. Rev. Cancer"},{"issue":"Suppl. B","key":"BFng470_CR3","doi-asserted-by":"publisher","first-page":"B75","DOI":"10.1269\/jrr.47.B75","volume":"47","author":"JF Crow","year":"2006","unstructured":"Crow, J.F. Age and sex effects on human mutation rates: an old problem with new complexities. J. Radiat. Res. (Tokyo) 47 (Suppl. B), B75\u2013B82 (2006).","journal-title":"J. Radiat. Res. (Tokyo)"},{"key":"BFng470_CR4","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0046-8177(94)90062-0","volume":"25","author":"JN Eble","year":"1994","unstructured":"Eble, J.N. Spermatocytic seminoma. Hum. Pathol. 25, 1035\u20131042 (1994).","journal-title":"Hum. Pathol."},{"key":"BFng470_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1046\/j.1365-2559.2003.01587.x","volume":"42","author":"E Rajpert-De Meyts","year":"2003","unstructured":"Rajpert-De Meyts, E. et al. The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma. Histopathology 42, 217\u2013226 (2003).","journal-title":"Histopathology"},{"key":"BFng470_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng0395-321","volume":"9","author":"PL Tavormina","year":"1995","unstructured":"Tavormina, P.L. et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9, 321\u2013328 (1995).","journal-title":"Nat. Genet."},{"key":"BFng470_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/12615","volume":"23","author":"D Cappellen","year":"1999","unstructured":"Cappellen, D. et al. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat. Genet. 23, 18\u201320 (1999).","journal-title":"Nat. Genet."},{"key":"BFng470_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/path.2207","volume":"213","author":"DC Tomlinson","year":"2007","unstructured":"Tomlinson, D.C., Baldo, O., Harnden, P. & Knowles, M.A. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J. Pathol. 213, 91\u201398 (2007).","journal-title":"J. Pathol."},{"key":"BFng470_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/genetics\/156.1.297","volume":"156","author":"MW Nachman","year":"2000","unstructured":"Nachman, M.W. & Crowell, S.L. Estimate of the mutation rate per nucleotide in humans. Genetics 156, 297\u2013304 (2000).","journal-title":"Genetics"},{"key":"BFng470_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/humu.10147","volume":"21","author":"AS Kondrashov","year":"2002","unstructured":"Kondrashov, A.S. Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases. Hum. Mutat. 21, 12\u201327 (2002).","journal-title":"Hum. Mutat."},{"key":"BFng470_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/molbev\/msj060","volume":"23","author":"J Taylor","year":"2006","unstructured":"Taylor, J., Tyekucheva, S., Zody, M., Chiaromonte, F. & Makova, K.D. Strong and weak male mutation bias at different sites in the primate genomes: insights from the human-chimpanzee comparison. Mol. Biol. Evol. 23, 565\u2013573 (2006).","journal-title":"Mol. Biol. Evol."},{"key":"BFng470_CR12","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/ajmg.a.31383","volume":"140A","author":"J B\u00f6hm","year":"2006","unstructured":"B\u00f6hm, J., Munk-Schulenburg, S., Felscher, S. & Kohlhase, J. SALL1 mutations in sporadic Townes-Brocks syndrome are of predominantly paternal origin without obvious paternal age effect. Am. J. Med. Genet. 140A, 1904\u20131908 (2006).","journal-title":"Am. J. Med. Genet."},{"key":"BFng470_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nrg2529","volume":"10","author":"N Arnheim","year":"2009","unstructured":"Arnheim, N. & Calabrese, P. Understanding what determines the frequency and pattern of human germline mutations. Nat. Rev. Genet. 10, 478\u2013488 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"BFng470_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ng0596-48","volume":"13","author":"DM Moloney","year":"1996","unstructured":"Moloney, D.M. et al. Exclusive paternal origin of new mutations in Apert syndrome. Nat. Genet. 13, 48\u201353 (1996).","journal-title":"Nat. Genet."},{"key":"BFng470_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1086\/302000","volume":"63","author":"DJ Wilkin","year":"1998","unstructured":"Wilkin, D.J. et al. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am. J. Hum. Genet. 63, 711\u2013716 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng470_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/humu.20381","volume":"27","author":"K Sol-Church","year":"2006","unstructured":"Sol-Church, K., Stabley, D.L., Nicholson, L., Gonzalez, I.L. & Gripp, K.W. Paternal bias in parental origin of HRAS mutations in Costello syndrome. Hum. Mutat. 27, 736\u2013741 (2006).","journal-title":"Hum. Mutat."},{"key":"BFng470_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/humu.20431","volume":"28","author":"G Zampino","year":"2007","unstructured":"Zampino, G. et al. Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. Hum. Mutat. 28, 265\u2013272 (2007).","journal-title":"Hum. Mutat."},{"key":"BFng470_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1086\/423493","volume":"75","author":"M Tartaglia","year":"2004","unstructured":"Tartaglia, M. et al. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. Am. J. Hum. Genet. 75, 492\u2013497 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng470_CR19","first-page":"1076","volume":"55","author":"KM Carlson","year":"1994","unstructured":"Carlson, K.M. et al. Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am. J. Hum. Genet. 55, 1076\u20131082 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng470_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/bdrc.20141","volume":"87","author":"M Dym","year":"2009","unstructured":"Dym, M., Kokkinaki, M. & He, Z. Spermatogonial stem cells: mouse and human comparisons. Birth Defects Res. C 87, 27\u201334 (2009).","journal-title":"Birth Defects Res. C"},{"key":"BFng470_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1085710","volume":"301","author":"A Goriely","year":"2003","unstructured":"Goriely, A., McVean, G.A.T., R\u00f6jmyr, M., Ingemarsson, B. & Wilkie, A.O.M. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301, 643\u2013646 (2003).","journal-title":"Science"},{"key":"BFng470_CR22","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1073\/pnas.0500267102","volume":"102","author":"A Goriely","year":"2005","unstructured":"Goriely, A. et al. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc. Natl. Acad. Sci. USA 102, 6051\u20136056 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng470_CR23","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1371\/journal.pbio.0050224","volume":"5","author":"J Qin","year":"2007","unstructured":"Qin, J. et al. The molecular anatomy of spontaneous germline mutations in human testes. PLoS Biol. 5, e224 (2007).","journal-title":"PLoS Biol."},{"key":"BFng470_CR24","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.1073\/pnas.0801267105","volume":"105","author":"S-K Choi","year":"2008","unstructured":"Choi, S.-K., Yoon, S.-R., Calabrese, P. & Arnheim, N. A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations. Proc. Natl. Acad. Sci. USA 105, 10143\u201310148 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng470_CR25","doi-asserted-by":"publisher","first-page":"e1000558","DOI":"10.1371\/journal.pgen.1000558","volume":"5","author":"S-R Yoon","year":"2009","unstructured":"Yoon, S.-R. et al. The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect. PLoS Genet. 5, e1000558 (2009).","journal-title":"PLoS Genet."},{"key":"BFng470_CR26","doi-asserted-by":"publisher","first-page":"14952","DOI":"10.1073\/pnas.232568699","volume":"99","author":"I Tiemann-Boege","year":"2002","unstructured":"Tiemann-Boege, I. et al. The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect. Proc. Natl. Acad. Sci. USA 99, 14952\u201314957 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng470_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cytogfr.2005.03.001","volume":"16","author":"AOM Wilkie","year":"2005","unstructured":"Wilkie, A.O.M. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 16, 187\u2013203 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFng470_CR28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.fertnstert.2007.04.037","volume":"89","author":"M Dakouane Giudicelli","year":"2008","unstructured":"Dakouane Giudicelli, M. et al. Increased achondroplasia mutation frequency with advanced age and evidence for G1138A mosaicism in human testis biopsies. Fertil. Steril. 89, 1651\u20131656 (2008).","journal-title":"Fertil. Steril."},{"key":"BFng470_CR29","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1038\/sj.onc.1210529","volume":"26","author":"PM Pollock","year":"2007","unstructured":"Pollock, P.M. et al. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene 26, 7158\u20137162 (2007).","journal-title":"Oncogene"},{"key":"BFng470_CR30","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.1073\/pnas.0803379105","volume":"105","author":"A Dutt","year":"2008","unstructured":"Dutt, A. et al. Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc. Natl. Acad. Sci. USA 105, 8713\u20138717 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng470_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/path.1816","volume":"207","author":"RMS Hansen","year":"2005","unstructured":"Hansen, R.M.S., Goriely, A., Wall, S.A., Roberts, I.S.D. & Wilkie, A.O.M. Fibroblast growth factor receptor 2, gain-of-function mutations, and tumourigenesis: investigating a potential link. J. Pathol. 207, 27\u201331 (2005).","journal-title":"J. Pathol."},{"key":"BFng470_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/gcc.20265","volume":"45","author":"G Bignell","year":"2006","unstructured":"Bignell, G. et al. Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults. Genes Chromosom. Cancer 45, 42\u201346 (2006).","journal-title":"Genes Chromosom. Cancer"},{"key":"BFng470_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2605.1987.tb00161.x","volume":"10","author":"NE Skakkeb\u00e6k","year":"1987","unstructured":"Skakkeb\u00e6k, N.E., Berthelsen, J.G., Giwercman, A. & M\u00fcller, J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int. J. Androl. 10, 19\u201328 (1987).","journal-title":"Int. J. Androl."},{"key":"BFng470_CR34","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1038\/sj.jid.5700804","volume":"127","author":"C Hafner","year":"2007","unstructured":"Hafner, C. et al. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J. Invest. Dermatol. 127, 1883\u20131885 (2007).","journal-title":"J. Invest. Dermatol."},{"key":"BFng470_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/ng0797-260","volume":"16","author":"M Chesi","year":"1997","unstructured":"Chesi, M. et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat. Genet. 16, 260\u2013264 (1997).","journal-title":"Nat. Genet."},{"key":"BFng470_CR36","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1086\/316892","volume":"67","author":"GA Bellus","year":"2000","unstructured":"Bellus, G.A. et al. Distinct missense mutations of the FGFR3 Lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. Am. J. Hum. Genet. 67, 1411\u20131421 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng470_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.molcel.2007.06.028","volume":"27","author":"H Chen","year":"2007","unstructured":"Chen, H. et al. A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol. Cell 27, 717\u2013730 (2007).","journal-title":"Mol. Cell"},{"key":"BFng470_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ajmg.1320590218","volume":"59","author":"IM Orioli","year":"1995","unstructured":"Orioli, I.M., Castilla, E.E., Scarano, G. & Mastroiacovo, P. Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. Am. J. Med. Genet. 59, 209\u2013217 (1995).","journal-title":"Am. J. Med. Genet."},{"key":"BFng470_CR39","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1002\/ajmg.a.32485","volume":"146A","author":"DK Waller","year":"2008","unstructured":"Waller, D.K. et al. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am. J. Med. Genet. 146A, 2385\u20132389 (2008).","journal-title":"Am. J. Med. Genet."},{"key":"BFng470_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ajmg.a.32085","volume":"146A","author":"A Zankl","year":"2008","unstructured":"Zankl, A. et al. Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation. Am. J. Med. Genet. 146A, 212\u2013218 (2008).","journal-title":"Am. J. Med. Genet."},{"key":"BFng470_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/EJE-08-0393","volume":"159","author":"L Castro-Feij\u00f3o","year":"2008","unstructured":"Castro-Feij\u00f3o, L. et al. Hypochondroplasia and acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene? Eur. J. Endocrinol. 159, 243\u2013249 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"BFng470_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/sj.ejhg.5200883","volume":"10","author":"BWG van Rhijn","year":"2002","unstructured":"van Rhijn, B.W.G. et al. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders. Eur. J. Hum. Genet. 10, 819\u2013824 (2002).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFng470_CR43","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/hmg\/10.12.1255","volume":"10","author":"T Iwata","year":"2001","unstructured":"Iwata, T., Li, C.-L., Deng, C.-X. & Francomano, C.A. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum. Mol. Genet. 10, 1255\u20131264 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFng470_CR44","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1093\/hmg\/9.11.1603","volume":"9","author":"T Iwata","year":"2000","unstructured":"Iwata, T. et al. A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum. Mol. Genet. 9, 1603\u20131613 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFng470_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0092-8674(86)90495-2","volume":"44","author":"CJ Der","year":"1986","unstructured":"Der, C.J., Finkel, T. & Cooper, G.M. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell 44, 167\u2013176 (1986).","journal-title":"Cell"},{"key":"BFng470_CR46","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/humu.20748","volume":"29","author":"Y Aoki","year":"2008","unstructured":"Aoki, Y., Niihori, T., Narumi, Y., Kure, S. & Matsubara, Y. The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum. Mutat. 29, 992\u20131006 (2008).","journal-title":"Hum. Mutat."},{"key":"BFng470_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1073\/pnas.82.1.38","volume":"82","author":"SK Srivastava","year":"1985","unstructured":"Srivastava, S.K., Yuasa, Y., Reynolds, S.H. & Aaronson, S.A. Effects of two major activating lesions on the structure and conformation of human ras oncogene products. Proc. Natl. Acad. Sci. USA 82, 38\u201342 (1985).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng470_CR48","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/humrep\/dem126","volume":"22","author":"A Juul","year":"2007","unstructured":"Juul, A. et al. Preserved fertility in a non-mosaic Klinefelter patient with a mutation in the fibroblast growth factor receptor 3 gene: Case Report. Hum. Reprod. 22, 1907\u20131911 (2007).","journal-title":"Hum. Reprod."},{"key":"BFng470_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.devcel.2007.01.002","volume":"12","author":"T Nakagawa","year":"2007","unstructured":"Nakagawa, T., Nabeshima, Y. & Yoshida, S. Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. Dev. Cell 12, 195\u2013206 (2007).","journal-title":"Dev. Cell"},{"key":"BFng470_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.stem.2009.04.020","volume":"5","author":"J Lee","year":"2009","unstructured":"Lee, J. et al. Genetic reconstruction of mouse spermatogonial stem cell self-renewal in vitro by Ras-cyclin D2 activation. Cell Stem Cell 5, 76\u201386 (2009).","journal-title":"Cell Stem Cell"},{"key":"BFng470_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1634\/stemcells.2007-0436","volume":"26","author":"Z He","year":"2008","unstructured":"He, Z. et al. Gdnf upregulates c-Fos transcription via the Ras\/Erk1\/2 pathway to promote mouse spermatogonial stem cell proliferation. Stem Cells 26, 266\u2013278 (2008).","journal-title":"Stem Cells"},{"key":"BFng470_CR52","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1126\/science.287.5457.1489","volume":"287","author":"X Meng","year":"2000","unstructured":"Meng, X. et al. Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 287, 1489\u20131493 (2000).","journal-title":"Science"},{"key":"BFng470_CR53","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.1038\/sj.onc.1206798","volume":"22","author":"YM Agazie","year":"2003","unstructured":"Agazie, Y.M., Movilla, N., Ischenko, I. & Hayman, M.J. The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3. Oncogene 22, 6909\u20136918 (2003).","journal-title":"Oncogene"},{"key":"BFng470_CR54","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1038\/sj.onc.1208705","volume":"24","author":"AH Jebar","year":"2005","unstructured":"Jebar, A.H. et al. FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene 24, 5218\u20135225 (2005).","journal-title":"Oncogene"},{"key":"BFng470_CR55","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ng2096","volume":"39","author":"V Shukla","year":"2007","unstructured":"Shukla, V., Coumoul, X., Wang, R.-H., Kim, H.-S. & Deng, C.-X. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat. Genet. 39, 1145\u20131150 (2007).","journal-title":"Nat. Genet."},{"key":"BFng470_CR56","doi-asserted-by":"publisher","first-page":"18930","DOI":"10.1073\/pnas.0806556105","volume":"105","author":"M Krenz","year":"2008","unstructured":"Krenz, M. et al. Role of ERK1\/2 signaling in congenital valve malformations in Noonan syndrome. Proc. Natl. Acad. Sci. USA 105, 18930\u201318935 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng470_CR57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1158\/0008-5472.CAN-05-2936","volume":"66","author":"LHJ Looijenga","year":"2006","unstructured":"Looijenga, L.H.J. et al. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res. 66, 290\u2013302 (2006).","journal-title":"Cancer Res."},{"key":"BFng470_CR58","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1093\/hmg\/ddp195","volume":"18","author":"S Ota","year":"2009","unstructured":"Ota, S., Zhou, Z.Q., Link, J.M. & Hurlin, P.J. The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects. Hum. Mol. Genet. 18, 2609\u20132621 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFng470_CR59","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrg1940","volume":"7","author":"P Khaitovich","year":"2006","unstructured":"Khaitovich, P., Enard, W., Lachmann, M. & P\u00e4\u00e4bo, S. Evolution of primate gene expression. Nat. Rev. Genet. 7, 693\u2013702 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"BFng470_CR60","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ng.f.136","volume":"40","author":"W Bodmer","year":"2008","unstructured":"Bodmer, W. & Bonilla, C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40, 695\u2013701 (2008).","journal-title":"Nat. Genet."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng.470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.470","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:09:21Z","timestamp":1684426161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng.470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,25]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFng470"],"URL":"https:\/\/doi.org\/10.1038\/ng.470","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1583957.1074055","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,25]]}}}